In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma.

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles